日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分在接受化疗、曲妥珠单抗和帕妥珠单抗一线治疗的HER2阳性晚期乳腺癌患者中的应用

Sánchez-Bayona, Rodrigo; Martínez-Sáez, Olga; Romero-Romero, Denys; Seguí, Elia; Carcelero, Esther; Tolosa, Pablo; Soberino, Jesús; Alva, Manuel; Pascual, Tomás; Lema, Laura; Garcia-Fructuoso, Isabel; Cobos-Fernandez, Maria Angeles; Rey, Maria; Manso, Luis; Aguirre, Angela; Madariaga, Ainhoa; Sirenko, Valeria; González-Deza, Cristina; Blasco, Paula; Mayhua, Astrid; Castillo, Oleguer; Galván, Patricia; Sanfeliu, Esther; Villacampa, Guillermo; Buckingham, Wesley; Marín-Aguilera, Mercedes; Paré, Laia; Villagrasa, Patricia; Perou, Charles M; Maues, Julia; Brasó-Maristany, Fara; Ciruelos, Eva; Prat, Aleix

Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

利用 9p21 缺失引起的乘客 ACO1 缺陷来杀死 T 细胞淋巴母细胞肿瘤细胞

Laura Gonzalez-Sanchez, Maria A Cobos-Fernandez, Pilar Lopez-Nieva, Maria Villa-Morales, Konstantinos Stamatakis, Jose M Cuezva, Jose L Marin-Rubio, Irene Vazquez-Dominguez, Iria Gonzalez-Vasconcellos, Eduardo Salido, Pilar Llamas, Jose L Lopez-Lorenzo, Javier Santos, Jose Fernandez-Piqueras